WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for AXSM

Based on 8 analysts offering 12 month price targets for Axsome Therapeutics Inc.
Min Forecast
$105.00+15.41%
Avg Forecast
$125.63+38.08%
Max Forecast
$180.00+97.85%

Should I buy or sell AXSM stock?

Based on 8 analysts offering ratings for Axsome Therapeutics Inc.
Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AXSM stock forecasts and price targets.

AXSM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-04
lockedlocked$00.00+00.00%2024-09-20
lockedlocked$00.00+00.00%2024-09-05
lockedlocked$00.00+00.00%2024-09-03
lockedlocked$00.00+00.00%2024-08-06
Bank of America
Top 20%
81
Strong BuyUpgrades$106.00+16.51%2024-08-06Find out why
Needham
Top 2%
99
BuyReiterates$130.00+42.89%2024-08-06
Mizuho
Top 30%
71
Strong BuyReiterates$106.00+16.51%2024-06-12

1 of 1

Forecast return on equity

Is AXSM forecast to generate an efficient return?
Company
322.95%
Industry
148.81%
Market
71.71%
AXSM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AXSM forecast to generate an efficient return on assets?
Company
60.59%
Industry
22.99%
AXSM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AXSM earnings per share forecast

What is AXSM's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
-$5.12
Avg 2 year Forecast
-$1.34
Avg 3 year Forecast
$4.70

AXSM revenue forecast

What is AXSM's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$373.8M+28.25%
Avg 2 year Forecast
$635.9M+118.15%
Avg 3 year Forecast
$1.1B+273.47%
AXSM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AXSM revenue growth forecast

How is AXSM forecast to perform vs Biotechnology companies and vs the US market?
Company
53.14%
Industry
34.94%
Market
9.19%
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AXSM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AXSM$90.98$125.63+38.08%Strong Buy
DNLI$31.58$40.71+28.92%Strong Buy
IMVT$31.14$45.40+45.79%Strong Buy
CRSP$54.86$79.25+44.46%Buy
RARE$50.73$86.25+70.02%Strong Buy

Axsome Therapeutics Stock Forecast FAQ

Is Axsome Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: AXSM) stock is to Strong Buy AXSM stock.

Out of 8 analysts, 5 (62.5%) are recommending AXSM as a Strong Buy, 3 (37.5%) are recommending AXSM as a Buy, 0 (0%) are recommending AXSM as a Hold, 0 (0%) are recommending AXSM as a Sell, and 0 (0%) are recommending AXSM as a Strong Sell.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.

What is AXSM's earnings growth forecast for 2024-2026?

(NASDAQ: AXSM) Axsome Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.49%.

Axsome Therapeutics's earnings in 2024 is -$308,552,000.On average, 8 Wall Street analysts forecast AXSM's earnings for 2024 to be -$245,881,050, with the lowest AXSM earnings forecast at -$337,921,443, and the highest AXSM earnings forecast at -$177,600,759. On average, 10 Wall Street analysts forecast AXSM's earnings for 2025 to be -$64,272,274, with the lowest AXSM earnings forecast at -$242,401,035, and the highest AXSM earnings forecast at $55,200,236.

In 2026, AXSM is forecast to generate $225,408,963 in earnings, with the lowest earnings forecast at $26,400,113 and the highest earnings forecast at $441,601,886.

What is AXSM's revenue growth forecast for 2024-2026?

(NASDAQ: AXSM) Axsome Therapeutics's forecast annual revenue growth rate of 53.14% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.19%.

Axsome Therapeutics's revenue in 2024 is $291,489,000.On average, 7 Wall Street analysts forecast AXSM's revenue for 2024 to be $17,943,916,635, with the lowest AXSM revenue forecast at $17,251,273,677, and the highest AXSM revenue forecast at $18,782,480,217. On average, 7 Wall Street analysts forecast AXSM's revenue for 2025 to be $30,522,322,355, with the lowest AXSM revenue forecast at $22,548,576,301, and the highest AXSM revenue forecast at $35,431,063,320.

In 2026, AXSM is forecast to generate $52,253,743,166 in revenue, with the lowest revenue forecast at $44,491,390,015 and the highest revenue forecast at $63,026,669,175.

What is AXSM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AXSM) forecast ROA is 60.59%, which is higher than the forecast US Biotechnology industry average of 22.99%.

What is AXSM's Price Target?

According to 8 Wall Street analysts that have issued a 1 year AXSM price target, the average AXSM price target is $125.63, with the highest AXSM stock price forecast at $180.00 and the lowest AXSM stock price forecast at $105.00.

On average, Wall Street analysts predict that Axsome Therapeutics's share price could reach $125.63 by Oct 4, 2025. The average Axsome Therapeutics stock price prediction forecasts a potential upside of 38.08% from the current AXSM share price of $90.98.

What is AXSM's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: AXSM) Axsome Therapeutics's current Earnings Per Share (EPS) is -$6.56. On average, analysts forecast that AXSM's EPS will be -$5.12 for 2024, with the lowest EPS forecast at -$7.04, and the highest EPS forecast at -$3.70. On average, analysts forecast that AXSM's EPS will be -$1.34 for 2025, with the lowest EPS forecast at -$5.05, and the highest EPS forecast at $1.15. In 2026, AXSM's EPS is forecast to hit $4.70 (min: $0.55, max: $9.20).

What is AXSM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AXSM) forecast ROE is 322.95%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.